CHICAGO -- Hitting rheumatoid arthritis (RA) early and hard, with targeted therapies as first-line treatment, appears to ...

New research presented at ACR 2025 shows GLP-1 receptor agonists, used for diabetes and obesity, may reduce rheumatoid ...

Researchers compared COVID-19 outcomes in rheumatoid arthritis patients treated with biologic vs conventional DMARDs.

“The true prevalence of nonadherence to DMARDs in RA is unknown, and the factors that are associated with nonadherence have not been clearly defined,” the authors note. “This is further complicated by ...

Several factors — but not older age — increased infection risk with the use of non-TNF biologics following first-line ...

MRI scans may be useful to monitor disease activity and detect active inflammation in axial spondyloarthritis, with the results influencing clinical decisions.

Health care resource use increased in patients with Sjögren disease during the year after diagnosis, especially among those with comorbid autoimmune disorders.

Treatment with guselkumab led to improvements in disease activity over 1 year among patients with PsA and showed a high retention rate.

Juvenile idiopathic arthritis (JIA) encompasses a group of pediatric inflammatory arthritides that includes oligoarticular JIA, polyarticular JIA, systemic JIA, psoriatic JIA, and enthesitis-related ...